STOCK TITAN

Envoy Medical (COCH): Nantahala reports 9.99% position in company

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Envoy Medical, Inc. Schedule 13G reports that Nantahala Capital Management, LLC and its managing members, Wilmot B. Harkey and Daniel Mack, may be deemed beneficial owners of 7,683,798 shares of Class A Common Stock, representing 9.99% of the class as of March 31, 2026. The disclosed holdings include 33,798 shares that may be acquired within sixty days through the exercise of convertible securities. The filing shows shared voting and dispositive power over the 7,683,798 shares and reports no sole voting or dispositive power.

Positive

  • None.

Negative

  • None.

Insights

Holders report a near-10% passive stake with shared control over holdings.

The filing states Nantahala and its principals beneficially own 7,683,798 shares (9.99%) as of March 31, 2026, with shared voting and dispositive power. This indicates coordinated ownership through an investment-advisory structure rather than sole control.

Key dependencies include the convertible securities that allow acquisition of 33,798 shares within sixty days and any future amendments to ownership percentages; subsequent filings will disclose changes in position.

Stake size is material for disclosure but does not by itself alter governance control.

The filing attributes shared voting and dispositive authority to Nantahala and names Messrs. Harkey and Mack as control persons; it does not report sole voting power. The structure is typical for an investment adviser managing client accounts.

Cash-flow treatment or plans to buy/sell are not stated in the excerpt; future Schedule 13D/13G or Form 4 filings would reflect any active changes.

Beneficial ownership 7,683,798 shares As of March 31, 2026
Percent of class 9.99% As of March 31, 2026
Shares exercisable within 60 days 33,798 shares Included in the 7,683,798 total
beneficial owner regulatory
"Nantahala may be deemed to be the beneficial owner of 7,683,798 Shares"
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
shared dispositive power regulatory
"Shared Dispositive Power 7,683,798.00"
convertible securities financial
"Include 33,798 Shares which may be acquired ... through the exercise of convertible securities"
Convertible securities are bonds or preferred shares that can be exchanged for a company’s common stock at a predetermined price or under specified conditions. They matter because they combine the steadiness of a loan or fixed dividend with the potential upside of ownership; like a safety‑net that carries a one‑time ticket to become a shareholder, they affect expected returns and can dilute existing stock if converted.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What stake does Nantahala list in Envoy Medical (COCH)?

Nantahala reports beneficial ownership of 7,683,798 shares, equal to 9.99% of Class A Common Stock as of March 31, 2026. The filing attributes shared voting and dispositive power over those shares to Nantahala and the two named principals.

Do the Reporting Persons have sole voting or dispositive power?

No. The Schedule 13G states each Reporting Person has 0 sole voting and 0 sole dispositive power. The filing records shared voting and shared dispositive power for 7,683,798 shares among the Reporting Persons.

Are any additional shares exercisable soon by the Reporting Persons?

Yes. The filing discloses that the 7,683,798 shares include 33,798 shares that may be acquired within sixty days upon exercise of convertible securities. The filing ties that exercisable amount to the total beneficial ownership figure.

Does this Schedule 13G indicate the Reporting Persons will change control?

No explicit change-of-control action is stated. The Schedule 13G reports passive beneficial ownership and shared powers; it does not state any transaction plan or intent to alter governance in the provided excerpt.





29415V109

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Nantahala Capital Management, LLC
Signature:/s/ Taki Vasilakis
Name/Title:Taki Vasilakis / Chief Compliance Officer
Date:05/15/2026
Wilmot B. Harkey
Signature:/s/ Wilmot B. Harkey
Name/Title:Wilmot B. Harkey
Date:05/15/2026
Daniel Mack
Signature:/s/ Daniel Mack
Name/Title:Daniel Mack
Date:05/15/2026